The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
PET radiotracers: crossing the blood–brain barrier and surviving metabolism
Open accessAbstract
Radiotracers for imaging protein targets in living human brain with positron emission tomography (PET) are increasingly useful in clinical research and in drug development. Such radiotracers must fulfill many criteria, among which an ability to enter brain adequately and reversibly without contamination by troublesome radiometabolites is desirable for accurate measurement of the density of a target protein (e.g., neuroreceptor, transporter, enzyme or plaque). Candidate radiotracers may fail as a result of poor passive brain entry, rejection from brain by efflux transporters or undesirable metabolism. These issues are reviewed. Emerging PET radiotracers for measuring efflux transporter function, and new strategies for ameliorating radiotracer metabolism are discussed. A growing understanding of the molecular features affecting the brain penetration, metabolism and efflux transporter sensitivity of prospective radiotracers should ultimately lead to their more rational and efficient design, and also to their greater efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Houle, S., Huang, S.-C., Ichise, M., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600493 · Cited by 1,955
Waterhouse, R. (2003) · Molecular Imaging & Biology · doi:10.1016/j.mibio.2003.09.014 · Cited by 567
Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion
Fischer, H., Gottschlich, R., & Seelig, A. (1998) · Journal of Membrane Biology · doi:10.1007/s002329900434 · Cited by 371
Syvänen, S., Lindhe, Ö., Palner, M., Kornum, B. R., Rahman, O., Långström, B., Knudsen, G. M., & Hammarlund-Udenaes, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024745 · Cited by 359
Farde, L., Ehrin, E., Eriksson, L., Greitz, T., Hall, H., Hedström, C. G., Litton, J. E., & Sedvall, G. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3863 · Cited by 300
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
Dallas, S., Miller, D. S., & Bendayan, R. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.3 · Cited by 296
Handbook of Radiopharmaceuticals: Radiochemistry and Applications
(2002) · Wiley eBooks · doi:10.1002/0470846380 · Cited by 281
Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET
Gunn, R. N., Sargent, P. A., Bench, C. J., Rabiner, E. A., Osman, S., Pike, V. W., Hume, S. P., Grasby, P. M., & Lammertsma, A. A. (1998) · NeuroImage · doi:10.1006/nimg.1998.0379 · Cited by 272
Self-citationMukherjee, J., Christian, B. T., Dunigan, K. A., Shi, B., Narayanan, T. K., Satter, M., & Mantil, J. (2002) · Synapse · doi:10.1002/syn.10128 · Cited by 270
Laruelle, M. (2003) · Molecular Imaging & Biology · doi:10.1016/j.mibio.2003.09.009 · Cited by 228
Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635
Pike, V. W., McCarron, J. A., Lammertsma, A. A., Osman, S., Hume, S. P., Sargent, P. A., Bench, C. J., Cliffe, I. A., Fletcher, A., & Grasby, P. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00079-9 · Cited by 226
Self-citationLimburg, K. E., & Moran, M. A. (1986) · Springer Series on Environmental Management · doi:10.1007/978-1-4612-4874-3_6 · Cited by 223
P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design
Raub, T. J. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0500871 · Cited by 221
Fujita, M., Imaizumi, M., Zoghbi, S. S., Fujimura, Y., Farris, A. G., Suhara, T., Hong, J., Pike, V. W., & Innis, R. B. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.11.011 · Cited by 213
Self-citationGinovart, N., Wilson, A. A., Meyer, J. H., Hussey, D., & Houle, S. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200111000-00010 · Cited by 209
Wilson, A. A., Garcia, A., Parkes, J., McCormick, P., Stephenson, K. A., Houle, S., & Vasdev, N. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.12.009 · Cited by 205
Pauli-Magnus, C., von Richter, O., Burk, O., Ziegler, A., Mettang, T., Eichelbaum, M., & Fromm, M. F. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39245-6 · Cited by 204
Briard, E., Zoghbi, S. S., Imaizumi, M., Gourley, J. P., Shetty, H. U., Hong, J., Cropley, V., Fujita, M., Innis, R. B., & Pike, V. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0707370 · Cited by 193
Self-citationSummerfield, S. G., Stevens, A. J., Cutler, L., del Carmen Osuna, M., Hammond, B., Tang, S.-P., Hersey, A., Spalding, D. J., & Jeffrey, P. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092916 · Cited by 175
Zoghbi, S. S., Shetty, H. U., Ichise, M., Fujita, M., Imaizumi, M., Liow, J., Shah, J., Musachio, J. L., Pike, V. W., & Innis, R. B. (2006) · PubMed · Cited by 170
Self-citationUsing positron emission tomography to facilitate CNS drug development
Lee, C.-M., & Farde, L. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.04.004 · Cited by 168
Elsinga, P. H., Hendrikse, N. H., Bart, J., Vaalburg, W., & van Waarde, A. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384736 · Cited by 148
Schou, M., Halldin, C., Sóvágó, J., Pike, V. W., Hall, H., Gulyás, B. Z., Mozley, P. D., Dobson, D. R., Shchukin, E., Innis, R. B., et al. (2004) · Synapse · doi:10.1002/syn.20031 · Cited by 129
Self-citationFarde, L., Ito, H., Swahn, C., Pike, V. W., & Halldin, C. (1998) · PubMed · Cited by 121
Self-citationHalldin, C., Foged, C., Chou, Y.-H., Karlsson, P., Swahn, C.-G., Sandell, J., Sedvall, G., & Farde, L. (1998) · PubMed · Cited by 119
The Role of Size and Charge for Blood–Brain Barrier Permeation of Drugs and Fatty Acids
Seelig, A. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0055-y · Cited by 118
Lee, G. S., & Bendayan, R. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000036905.82914.8e · Cited by 116
Luurtsema, G., Molthoff, C. F. M., Schuit, R. C., Windhorst, A. D., Lammertsma, A. A., & Franssen, E. J. F. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.06.007 · Cited by 113
Fowler, J. S., Wolf, A. P., MacGregor, R. R., Dewey, S. L., Logan, J., Schlyer, D. J., & Långström, B. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb01121.x · Cited by 107
Toward an improved prediction of human in vivo brain penetration
Summerfield, S., Lucas, A. J., Porter, R., Jeffrey, P., Gunn, R., Read, K., Stevens, A. J., Metcalf, A., Osuna, M. C., Kilford, P., et al. (2008) · Xenobiotica; the fate of foreign compounds in biological systems · doi:10.1080/00498250802499459 · Cited by 101
PET-based molecular imaging in neuroscience
Jacobs, A. H., Li, H., Winkeler, A., Hilker, R., Knoess, C., R�ger, A., Galldiks, N., Schaller, B. J., Sobesky, J., Kracht, L. W., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1202-5 · Cited by 101
Zoghbi, S. S., Liow, J., Yasuno, F., Hong, J. S., Tuan, E. W., Lazarova, N., Gladding, R. L., Pike, V. W., & Innis, R. B. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047308 · Cited by 92
Self-citationOsman, S., Lundkvist, C., Pike, V. W., Halldin, C., McCarron, J. A., Swahn, C., Farde, L., Ginovart, N., Luthra, S. K., Gunn, R. N., et al. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00206-0 · Cited by 91
Self-citationDing, Y., Fowler, J. S., Logan, J., Wang, G., Telang, F., Garza, V., Biegon, A. R., Pareto, D., Rooney, W. D., Shea, C. E., et al. (2004) · Synapse · doi:10.1002/syn.20051 · Cited by 91
Donohue, S. R., Krushinski, J. H., Pike, V. W., Chernet, E., Phebus, L. A., Chesterfield, A. K., Felder, C. C., Halldin, C., & Schaus, J. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800416m · Cited by 90
Self-citationYasuno, F., Brown, A. K., Zoghbi, S. S., Krushinski, J. H., Chernet, E., Tauscher, J. T., Schaus, J. M., Phebus, L. A., Chesterfield, A. K., Felder, C. C., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301402 · Cited by 90
Self-citationDevelopment of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies
Kropholler, M. A., Boellaard, R., Schuitemaker, A., van Berckel, B. N. M., Luurtsema, G., Windhorst, A. D., & Lammertsma, A. A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600092 · Cited by 87
Briard, E., Zoghbi, S. S., Siméon, F. G., Imaizumi, M., Gourley, J. P., Shetty, H. U., Lu, S., Fujita, M., Innis, R. B., & Pike, V. W. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8011855 · Cited by 86
Self-citationLazarova, N., Zoghbi, S. S., Hong, J. S., Seneca, N. M., Tuan, E., Gladding, R. L., Liow, J., Taku, A., Innis, R. B., & Pike, V. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800510m · Cited by 85
Self-citationGerebtzoff, G., & Seelig, A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci0600814 · Cited by 82
Fujimura, Y., Zoghbi, S. S., Siméon, F. G., Taku, A., Pike, V. W., Innis, R. B., & Fujita, M. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060186 · Cited by 82
Self-citationPositron-emitting radioligands for studies in vivo-probes for human psychopharmacology
Pike, V. W. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700202 · Cited by 81
Self-citation[18F]Flumazenil binding to central benzodiazepine receptor studies by PET
Odano, I., Halldin, C., Karlsson, P., Varrone, A., Airaksinen, A. J., Красикова, Р. Н., & Farde, L. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.005 · Cited by 80
Siméon, F. G., Brown, A. K., Zoghbi, S. S., Patterson, V. M., Innis, R. B., & Pike, V. W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0701268 · Cited by 75
Self-citationFarde, L., Ginovart, N., Ito, H., Lundkvist, C., Pike, V. W., McCarron, J. A., & Halldin, C. (1997) · Psychopharmacology · doi:10.1007/s002130050391 · Cited by 72
Self-citationLiow, J., Lu, S., McCarron, J. A., et al. (2006) · Synapse · doi:10.1002/syn.20348 · Cited by 71
Hirvonen, J., Johansson, J. J., Teräs, M., Oikonen, V., Lumme, V., Virsu, P., Roivainen, A., Någren, K., Halldin, C., Farde, L., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600607 · Cited by 68
Handbook of radiopharmaceuticals. Radiochemistry and applications
(2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1224-z · Cited by 67
Tipre, D. N., Zoghbi, S. S., Liow, J., Green, M. V., Seidel, J., Ichise, M., Innis, R. B., & Pike, V. W. (2006) · PubMed · Cited by 66
Self-citationLiow, J., Kreisl, W. C., Zoghbi, S. S., Lazarova, N., Seneca, N. M., Gladding, R. L., Taku, A., Herscovitch, P., Pike, V. W., & Innis, R. B. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.056226 · Cited by 63
Self-citationSeneca, N. M., Zoghbi, S. S., Liow, J., Kreisl, W. C., Herscovitch, P., Jenko, K. J., Gladding, R. L., Taku, A., Pike, V. W., & Innis, R. B. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058453 · Cited by 62
Self-citationBrown, A. K., Kimura, Y., Zoghbi, S. S., Siméon, F. G., Liow, J., Kreisl, W. C., Taku, A., Fujita, M., Pike, V. W., & Innis, R. B. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.056291 · Cited by 61
Self-citationShetty, H. U., Zoghbi, S. S., Liow, J., Ichise, M., Hong, J. S., Musachio, J. L., Halldin, C., Seidel, J., Innis, R. B., & Pike, V. W. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0277-1 · Cited by 57
Self-citationDaSilva, J. N., Lourenco, C. M., Meyer, J., Hussey, D., Potter, W., & Houle, S. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0950-y · Cited by 55
Ryu, Y. H., Liow, J., Zoghbi, S. S., Fujita, M., Collins, J., Tipre, D. N., Sangare, J., Hong, J.-S., Pike, V. W., & Innis, R. B. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.039933 · Cited by 54
Self-citationOkamura, T., Kikuchi, T., Okada, M., Toramatsu, C., Fukushi, K., Takei, M., & Irie, T. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.135 · Cited by 52
Shetty, H. U., Zoghbi, S. S., Siméon, F. G., Liow, J., Brown, A. K., Kannan, P., Innis, R. B., & Pike, V. W. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143347 · Cited by 51
Self-citationIn vivo delineation of 5-HT1A receptors in human brain with [18F]MPPF.
Passchier, J., van Waarde, A., Pieterman, R., Elsinga, P. H., Pruim, J., Hendrikse, H. N., Willemsen, A. T. M., & Vaalburg, W. (2000) · PubMed · Cited by 50
Doze, P., van Waarde, A., Elsinga, P. H., Hendrikse, N. H., & Vaalburg, W. (2000) · Synapse · Cited by 49
Hinz, R., Bhagwagar, Z., Cowen, P., Cunningham, V., & Grasby, P. (2007) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/sj.jcbfm.9600323 · Cited by 49
Elsinga, P. H., Hendrikse, N. H., Bart, J., van Waarde, A., & Vaalburg, W. (2004) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0951-x · Cited by 47
Jones, A. K. P., Cunningham, V. J., Ha-Kawa, S., Fujiwara, T., Liyi, Q., Luthra, S. K., Ashburner, J., Osman, S., & Jones, T. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90002-7 · Cited by 47
Andrée, B., Halldin, C., Pike, V. W., Gunn, R. N., Olsson, H., & Farde, L. (2002) · PubMed · Cited by 41
Self-citationMatusch, A., Meyer, P. T., Bier, D. D., et al. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.07.006 · Cited by 26
McCarron, J. A., Zoghbi, S. S., Shetty, H. U., Vermeulen, E. S., Wikström, H., Ichise, M., Yasuno, F., Halldin, C., Innis, R. B., & Pike, V. W. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0460-z · Cited by 24
Self-citationYasuno, F., Sanabria, S., Burns, D. H., Hargreaves, R. J., Ghose, S., Ichise, M., Chin, F. T., Morse, C. L., Pike, V. W., & Innis, R. B. (2007) · Synapse · doi:10.1002/syn.20361 · Cited by 17
Self-citation
Cited by
The blood-brain barrier: an engineering perspective
Wong, A. D., Ye, M., Levy, A. F., Rothstein, J. D., Bergles, D. E., & Searson, P. C. (2013) · Frontiers in Neuroengineering · doi:10.3389/fneng.2013.00007 · Cited by 662
[ 18 F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Xia, C., Arteaga, J., Chen, G., Gangadharmath, U., Gomez, L. F., Kasi, D., Lam, C., Liang, Q., Liu, C., Mocharla, V. P., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.008 · Cited by 605
Tau imaging: early progress and future directions
Villemagne, V. L., Fodero-Tavoletti, M. T., Masters, C. L., & Rowe, C. C. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70252-2 · Cited by 501
Lo, C. H., & Zeng, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00362-0 · Cited by 117
Developments in Tau PET Imaging
Zimmer, E. R., Leuzy, A., Gauthier, S., & Rosa-Neto, P. (2014) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2014.15 · Cited by 60
Metadata
- Authors
- Pike, V. W.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 30
- Issue
- 8
- Pages
- 431-440
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2103312948
- Cited by
- 582
- References
- 67
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.